tirzepatide semaglutide compound Concerns Surrounding Compounded GLP-1s Mount As Shortages of Tirzepatide, End Overview of Tirzepatide and Semaglutide

Studies show that its safe to switch from one GLP-1 to another within 310 days of the last dose

BPC-157 / TB-500 Mix is a research-grade combination peptide that pairs two of the most extensively studied compounds in tissue repair research within a single vial 10mg of Body Protection Compound-157 and 10mg of Thymosin Beta-4 Fragment 17-23. The combination provides researchers with a single reagent for investigating complementary repair pathways, including angiogenesis-associated signalling, cellular migration, and extracellular matrix remodelling

Asking them to articulate their concerns opens a dialogue rather than creating a confrontation

You can do that online